CAITLYN BARRY: Open Payments
NPI 1275098402 · ROLLA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 34 payments from 14 companies in 2025. Trend: 2023 $408 · 2024 $426 · 2025 $589
Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $88 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Kowa Pharmaceuticals America, Inc. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| Lundbeck LLC | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Antares Pharma, Inc. | 1 | $19 |
Products named: REXULTI, ZORYVE, CAPLYTA, VRAYLAR, BREZTRI, TRINTELLIX, MOUNJARO, Kerendia.
Industry payments across MO — which companies pay providers there.
